Early creatinine and e-GFR changes as prognostic predictors of COVID-19 patients

Author:

Ahmet Karatas1ORCID,Ebru Canakci2ORCID,Emre Erdem3ORCID,Aykut Ozturan4ORCID,Yasemin Kaya5ORCID,Beyza Sayim5ORCID,Mervegul Kaya6ORCID

Affiliation:

1. Department of Neprology, School of Medicine , Ondokuz Mayis University , Ordu , Turkey

2. Department of Anesthesiology and Reanimation, School of Medicine , Ordu University , Ordu , Turkey

3. Dmed Private Dialysis Center , Samsun , Turkey

4. Clinic of Internal Medicine , Ordu State Hospital , Ordu , Turkey

5. Department of Internal Medicine, School of Medicine , Ordu University , Ordu , Turkey

6. Training and Research Hospital, Clinic of Family Medicine , Ordu University , Ordu , Turkey

Abstract

Abstract Objectives We aimed to investigate the effects of the COVID-19 disease on kidney functions and early prognosis. Methods All cases were divided into those discharged and exitus cases. The patients were diagnosed with acute kidney injury (AKI) according to the KDIGO criteria. Results As a result of the ROC analysis, the patients with a creatinine value above 1.05 for day 1 and 0.975 for creatinine value on day 7 would be mortal (AUC values of 0.641 (0.569–0.714) and 0.757 (0.689–0.825), respectively). As a result of Univariate analysis; D-Dimer, Procalcitonin, BUN and creatinine values are risk factors and a one-unit increase in these values is 1.184; 1.105; It was determined that it would increase 1.024 and 1.304 times (p values 0.008; 0.007; <0.001; 0.002), respectively. Decreased in e-GFR value would increase the risk of death 1.026 (1/0.975) times (p<0.001). Conclusions We observed the high creatinine, D-dimer, procalcitonin, ferritin, and low e-GFR levels were risk factors for severity and mortality for COVID-19 disease. While physicians and all stakeholders focus on the prognosis and mortality of the disease of COVID-19 disease, it is necessary to be thorough about kidney involvement as much as respiratory system involvement.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3